Search
for
Sort by
Research 841–870 of 1000+
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
- Subcellular localization of the five members of the human steroid 5α-reductase family
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- Alopecia androgénica femenina: nuevos factores fisiopatológicos y futuras tendencias para un abordaje clínico más integral
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α‐Reductase?
- Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Therapeutic potential of Ishophloroglucin a from Ishige okamurae in androgenic alopecia: inhibition of 5α-reductase activity and activation of the Wnt/β-catenin signaling pathway in human dermal papilla cells
- Fully automated chip-based nanoelectrospray ionization-mass spectrometry as an effective tool for rapid and high-throughput screening of 5α-reductase inhibitors
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- Androgenetic alopecia; drug safety and therapeutic strategies
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Androgens and Parkinson’s disease: the role in humans and in experiment
- DHT and E2 synthesis-related proteins and receptors expression in male yak skin during different hair follicle stages
- Unrevealing the Potential of Sansevieria trifasciata Prain Fraction for the Treatment of Androgenetic Alopecia by Inhibiting Androgen Receptors Based on LC-MS/MS Analysis, and In-Silico Studies
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Post-finasteride syndrome
- Hormonal manipulation of benign prostatic hyperplasia
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- “Sebocytes’ makeup” - Novel mechanisms and concepts in the physiology of the human sebaceous glands
- Effective treatment of female androgenic alopecia with dutasteride.
- Androgenic alopecia and dutasteride in hair mesotherapy: A short review
- Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Steroidogenic enzymes in skin.
- Dutasteride
- Phase-specific differential regulation of mechanical allodynia in a murine model of neuropathic pain by progesterone
- 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes